B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion

Journal of Experimental Medicine

Volumn 203, Issue 10, 2006, Pages 2305-2314

  Savitsky, David ^a   Calame, Kathryn ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; MESSENGER RNA; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; GENE REPRESSION; IMMUNOGLOBULIN PRODUCTION; INFLUENZA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; MICE; ORTHOMYXOVIRIDAE INFECTIONS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 33749332704     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060411     Document Type: Article

References (81)

1. Berland, R., and H.H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20:253-300.
2. Hayakawa, K., R.R. Hardy, D.R. Parks, and L.A. Herzenberg. 1983. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157:202-218.
3. Hayakawa, K., and R.R. Hardy. 2000. Development and function of B-1 cells. Curr. Opin. Immunol. 12:346-353.
4. Wortis, H.H., and R. Berland. 2001. Cutting edge commentary: origins of B-1 cells. J. Immunol. 166:2163-2166.
5. Montecino-Rodriguez, E., H. Leathers, and K. Dorshkind. 2006. Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 7:293-301.
6. Casola, S., K.L. Otipoby, M. Alimzhanov, S. Humme, N. Uyttersprot, J.L. Kutok, M.C. Carroll, and K. Rajewsky. 2004. B cell receptor signal strength determines B cell fate. Nat. Immunol. 5:317-327.
7. Forster, I., and K. Rajewsky. 1987. Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol. 17:521-528.
8. Hayakawa, K., R.R. Hardy, L.A. Herzenberg, and L.A. Herzenberg. 1985. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J. Exp. Med. 161:1554-1568.
9. Wardemann, H., T. Boehm, N. Dear, and R. Carsetti. 2002. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J. Exp. Med. 195:771-780.
10. Bos, N.A., C.G. Meeuwsen, B.S. Wostmann, J.R. Pleasants, and R. Benner. 1988. The influence of exogenous antigenic stimulation on the specificity repertoire of background immunoglobulin-secreting cells of different isotypes. Cell. Immunol. 112:371-380.
11. Kroese, F.G., E.C. Butcher, A.M. Stall, P.A. Lalor, S. Adams, and L.A. Herzenberg. 1989. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int. Immunol. 1:75-84.
12. Kantor, A.B., C.E. Merrill, L.A. Herzenberg, and J.L. Hillson. 1997. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J. Immunol. 158:1175-1186.
13. Hardy, R.R., C.E. Carmack, S.A. Shinton, R.J. Riblet, and K. Hayakawa. 1989. A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. J. Immunol. 142:3643-3651.
14. Su, S.D., M.M. Ward, M.A. Apicella, and R.E. Ward. 1991. The primary B cell response to the O/core region of bacterial lipopolysaccharide is restricted to the Ly-1 lineage. J. Immunol. 146:327-331.
15. Malynn, B.A., G.D. Yancopoulos, J.E. Barth, C.A. Bona, and F.W. Alt. 1990. Biased expression of JH-proximal VH genes occurs in the newly generated repertoire of neonatal and adult mice. J. Exp. Med. 171:843-859.
16. Masmoudi, H., T. Mota-Santos, F. Huetz, A. Coutinho, and P.A. Cazenave. 1990. All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int. Immunol. 2:515-520.
17. Baumgarth, N., O.C. Herman, G.C. Jager, L. Brown, L.A. Herzenberg, and L.A. Herzenberg. 1999. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. USA. 96:2250-2255.
18. Hayakawa, K., R.R. Hardy, M. Honda, L.A. Herzenberg, A.D. Steinberg, and L.A. Herzenberg. 1984. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl. Acad. Sci. USA. 81:2494-2498.
19. Forster, I., H. Gu, and K. Rajewsky. 1988. Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. EMBO J. 7:3693-3703.
20. Tornberg, U.C., and D. Holmberg. 1995. B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressures. EMBO J. 14:1680-1689.
21. Hayakawa, K., M. Asano, S.A. Shinton, M. Gui, D. Allman, C.L. Stewart, J. Silver, and R.R. Hardy. 1999. Positive selection of natural autoreactive B cells. Science. 285:113-116.
22. Wang, H., and S.H. Clarke. 2004. Regulation of B-cell development by antibody specificity. Curr. Opin. Immunol. 16:246-250.
23. Shaw, P.X., S. Horkko, M.K. Chang, L.K. Curtiss, W. Palinski, G.J. Silverman, and J.L. Witztum. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105:1731-1740.
24. Martin, F., and J.F. Kearney. 2000. B-cell subsets and the mature pre-immune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol. Rev. 175:70-79.
25. Martin, F., A.M. Oliver, and J.F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 14:617-629.
26. Baumgarth, N., O.C. Herman, G.C. Jager, L.E. Brown, L.A. Herzenberg, and J. Chen. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192:271-280.
27. Tsuji, R.F., M. Szczepanik, I. Kawikova, V. Paliwal, R.A. Campos, A. Itakura, M. Akahira-Azuma, N. Baumgarth, L.A. Herzenberg, and P.W. Askenase. 2002. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J. Exp. Med. 196:1277-1290.
28. Murakami, M., T. Tsubata, R. Shinkura, S. Nisitani, M. Okamoto, H. Yoshioka, T. Usui, S. Miyawaki, and T. Honjo. 1994. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J. Exp. Med. 180:111-121.
29. Zhang, M., W.G. Austen Jr., I. Chiu, E.M. Alicot, R. Hung, M. Ma, N. Verna, M. Xu, H.B. Hechtman, F.D. Moore Jr., and M.C. Carroll. 2004. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA. 101:3886-3891.
30. Okada, T., M. Abe, F. Takiura, S. Hirose, and T. Shirai. 1990. Distinct surface phenotypes of B cells responsible for spontaneous production of IgM and IgG anti-DNA antibodies in autoimmune-prone NZB x NZW F1 mice. Autoimmunity. 7:109-120.
31. Szczepanik, M., M. Akahira-Azuma, K. Bryniarski, R.F. Tsuji, I. Kawikova, W. Ptak, C. Kiener, R.A. Campos, and P.W. Askenase. 2003. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity. J. Immunol. 171:6225-6235.
32. Alugupalli, K.R., J.M. Leong, R.T. Woodland, M. Muramatsu, T. Honjo, and R.M. Gerstein. 2004. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity. 21:379-390.
33. Haas, K.M., J.C. Poe, D.A. Steeber, and T.F. Tedder. 2005. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity. 23:7-18.
34. Youinou, P., C. Jamin, and P.M. Lydyard. 1999. CD5 expression in human B-cell populations. Immunol. Today. 20:312-316.
35. Baumgarth, N., J.W. Tung, and L.A. Herzenberg. 2005. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 26:347-362.
36. Shapiro-Shelef, M., and K. Calame. 2005. Regulation of plasma-cell development. Nat. Rev. Immunol. 5:230-242.
37. Lin, K.I., C. Tunyaplin, and K. Calame. 2003. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol. Rev. 194:19-28.
38. Turner, C.A., Jr., D.H. Mack, and M.M. Davis. 1994. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell. 77:297-306.
39. Shaffer, A.L., K.I. Lin, T.C. Kuo, X. Yu, E.M. Hurt, A. Rosenwald, J.M. Giltnane, L. Yang, H. Zhao, K. Calame, and L.M. Staudt. 2002. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 17:51-62.
40. Kallies, A., J. Hasbold, D.M. Tarlinton, W. Dietrich, L.M. Corcoran, P.D. Hodgkin, and S.L. Nutt. 2004. Plasma cell ontogeny defined by quantitative changes in Blimp-1 expression. J. Exp. Med. 200:967-977.
41. Piskurich, J.F., K.I. Lin, Y. Lin, Y. Wang, J.P. Ting, and K. Calame. 2000. BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat. Immunol. 1:526-532.
42. Shapiro-Shelef, M., K.I. Lin, L.J. McHeyzer-Williams, J. Liao, M.G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity. 19:607-620.
43. Lin, Y., K. Wong, and K. Calame. 1997. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science. 276:596-599.
44. Lin, K.I., C. Angelin-Duclos, T.C. Kuo, and K. Calame. 2002. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell. Biol. 22:4771-4780.
45. Sciammas, R., and M.M. Davis. 2004. Modular nature of Blimp-1 in the regulation of gene expression during B cell maturation. J. Immunol. 172:5427-5440.
46. Neurath, M.F., W. Strober, and Y. Wakatsuki. 1994. The murine Ig 3′ alpha enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, S alpha-BP). J. Immunol. 153:730-742.
47. Rinkenberger, J.L., J.J. Wallin, K.W. Johnson, and M.E. Koshland. 1996. An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity. 5:377-386.
48. Singh, M., and B.K. Birshtein. 1993. NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′ alpha enhancer at early stages of B-cell differentiation. Mol. Cell. Biol. 13:3611-3622.
49. Shaffer, A.L., M. Shapiro-Shelef, N.N. Iwakoshi, A.H. Lee, S.B. Qian, H. Zhao, X. Yu, L. Yang, B.K. Tan, A. Rosenwald, et al. 2004. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity. 21:81-93.
50. Reimold, A.M., N.N. Iwakoshi, J. Manis, P. Vallabhajosyula, E. Szomolanyi-Tsuda, E.M. Gravallese, D. Friend, M.J. Grusby, F. Alt, and L.H. Glimcher. 2001. Plasma cell differentiation requires the transcription factor XBP-1. Nature. 412:300-307.
51. Tumang, J.R., R. Frances, S.G. Yeo, and T.L. Rothstein. 2005. Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J. Immunol. 174:3173-3177.
52. Rickert, R.C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25:1317-1318.
53. Morris, D.L., and T.L. Rothstein. 1993. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes. J. Exp. Med. 177:857-861.
54. Binder, C.J., and G.J. Silverman. 2005. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin. Immunopathol. 26:385-404.
55. Briles, D.E., C. Forman, S. Hudak, and J.L. Claflin. 1982. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J. Exp. Med. 156:1177-1185.
56. Desaymard, C., A.M. Giusti, and M.D. Scharff. 1984. Rat anti-T15 monoclonal antibodies with specificity for VH- and VH-VL epitopes. Mol. Immunol. 21:961-967.
57. Deenen, G.J., and F.G. Kroese. 1993. Kinetics of peritoneal B-1a cells (CD5 B cells) in young adult mice. Eur. J. Immunol. 23:12-16.
58. Barrington, R., M. Zhang, M. Fischer, and M.C. Carroll. 2001. The role of complement in inflammation and adaptive immunity. Immunol. Rev. 180:5-15.
59. Ochsenbein, A.F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R.M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 286:2156-2159.
60. Taylor, H.P., and N.J. Dimmock. 1985. Mechanisms of neutralization of influenza virus by IgM. J. Gen. Virol. 66:903-907.
61. Nera, K.P., P. Kohonen, E. Narvi, A. Peippo, L. Mustonen, P. Terho, K. Koskela, J.M. Buerstedde, and O. Lassila. 2006. Loss of Pax5 promotes plasma cell differentiation. Immunity. 24:283-293.
62. Delogu, A., A. Schebesta, Q. Sun, K. Aschenbrenner, T. Perlot, and M. Busslinger. 2006. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity. 24:269-281.
63. Iwakoshi, N.N., A.H. Lee, P. Vallabhajosyula, K.L. Otipoby, K. Rajewsky, and L.H. Glimcher. 2003. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat. Immunol. 4:321-329.
64. Abrahao, T.B., E. Freymuller, R.A. Mortara, J.D. Lopes, and M. Mariano. 2003. Morphological characterization of mouse B-1 cells. Immunobiology. 208:401-411.
65. Boes, M., C. Esau, M.B. Fischer, T. Schmidt, M. Carroll, and J. Chen. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160:4776-4787.
66. Ehrenstein, M.R., T.L. O'Keefe, S.L. Davies, and M.S. Neuberger. 1998. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc. Natl. Acad. Sci. USA. 95:10089-10093.
67. Kawahara, T., H. Ohdan, G. Zhao, Y.G. Yang, and M. Sykes. 2003. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J. Immunol. 171:5406-5414.
68. Ohdan, H., K.G. Swenson, H.S. Kruger Gray, Y.G. Yang, Y. Xu, A.D. Thall, and M. Sykes. 2000. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal alpha 1,3Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice. J. Immunol. 165:5518-5529.
69. Deenen, G.J., and F.G. Kroese. 1992. Murine peritoneal Ly-1 B cells do not turn over rapidly. Ann. NY Acad. Sci. 651:70-71.
70. Kretschmer, K., J. Stopkowicz, S. Scheffer, T.F. Greten, and S. Weiss. 2004. Maintenance of peritoneal B-1a lymphocytes in the absence of the spleen. J. Immunol. 173:197-204.
71. Ren, B., K.J. Chee, T.H. Kim, and T. Maniatis. 1999. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev. 13:125-137.
72. Yu, J., C. Angelin-Duclos, J. Greenwood, J. Liao, and K. Calame. 2000. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol. Cell. Biol. 20:2592-2603.
73. Gyory, I., J. Wu, G. Fejer, E. Seto, and K.L. Wright. 2004. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat. Immunol. 5:299-308.
74. Ancelin, K., U.C. Lange, P. Hajkova, R. Schneider, A.J. Bannister, T. Kouzarides, and M.A. Surani. 2006. Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat. Cell Biol. 8:623-630.
75. Tarte, K., F. Zhan, J. De Vos, B. Klein, and J. Shaughnessy Jr. 2003. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood. 102:592-600.
76. Hasbold, J., L.M. Corcoran, D.M. Tarlinton, S.G. Tangye, and P.D. Hodgkin. 2004. Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulate lymphocyte differentiation. Nat. Immunol. 5:55-63.
77. Steinberg, B.J., P.A. Smathers, K. Frederiksen, and A.D. Steinberg. 1982. Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. J. Clin. Invest. 70:587-597.
78. Dauphinee, M., Z. Tovar, and N. Talal. 1988. B cells expressing CD5 are increased in Sjogren's syndrome. Arthritis Rheum. 31:642-647.
79. Youinou, P., L. Mackenzie, P. Katsikis, G. Merdrignac, D.A. Isenberg, N. Tuaillon, A. Lamour, P. Le Goff, J. Jouquan, A. Drogou, et al. 1990. The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. Arthritis Rheum. 33:339-348.
80. Tobita, K., A. Sugiura, C. Enomote, and M. Furuyama. 1975. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med. Microbiol. Immunol. (Berl.). 162:9-14.
81. Angelin-Duclos, C., K. Johnson, J. Liao, K.I. Lin, and K. Calame. 2002. An interfering form of Blimp-1 increases IgM secreting plasma cells and blocks maturation of peripheral B cells. Eur. J. Immunol. 32:3765-3775.